A machine learning algorithm based on circulating metabolic biomarkers offers improved predictions of neurological diseases.
Journal:
Clinica chimica acta; international journal of clinical chemistry
PMID:
38621587
Abstract
BACKGROUND AND AIMS: A machine learning algorithm based on circulating metabolic biomarkers for the predictions of neurological diseases (NLDs) is lacking. To develop a machine learning algorithm to compare the performance of a metabolic biomarker-based model with that of a clinical model based on conventional risk factors for predicting three NLDs: dementia, Parkinson's disease (PD), and Alzheimer's disease (AD).